Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 4,480.00
+30.00 (0.67%)
At close: Feb 13, 2026
Genoray Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 102,751 | 106,982 | 97,897 | 82,604 | 74,290 | 61,688 |
Other Revenue | - | -0 | -0 | -0 | -0 | - |
| 102,751 | 106,982 | 97,897 | 82,604 | 74,290 | 61,688 | |
Revenue Growth (YoY) | -5.71% | 9.28% | 18.51% | 11.19% | 20.43% | -5.25% |
Cost of Revenue | 64,555 | 67,678 | 60,554 | 47,497 | 43,431 | 35,830 |
Gross Profit | 38,196 | 39,304 | 37,343 | 35,107 | 30,859 | 25,858 |
Selling, General & Admin | 23,262 | 19,820 | 17,715 | 13,708 | 10,743 | 9,401 |
Research & Development | 11,885 | 8,881 | 4,262 | 3,513 | 2,957 | 2,646 |
Amortization of Goodwill & Intangibles | 2,127 | 2,445 | 1,145 | 1,111 | 1,313 | 1,273 |
Other Operating Expenses | 296.42 | 177.07 | 440.95 | 252.45 | 162.25 | 210.12 |
Operating Expenses | 39,917 | 32,795 | 24,586 | 20,189 | 15,891 | 14,739 |
Operating Income | -1,722 | 6,509 | 12,757 | 14,918 | 14,968 | 11,119 |
Interest Expense | -1,222 | -962.53 | -557.87 | -195.09 | -176.23 | -239.21 |
Interest & Investment Income | 611.44 | 654.58 | 817.2 | 809.69 | 234.88 | 250.67 |
Currency Exchange Gain (Loss) | 1,075 | 1,419 | -212.61 | 103.18 | 513.11 | -458.54 |
Other Non Operating Income (Expenses) | -461.1 | -77.81 | 146.16 | 54.12 | 207.16 | 26.99 |
EBT Excluding Unusual Items | -1,718 | 7,543 | 12,950 | 15,690 | 15,747 | 10,699 |
Impairment of Goodwill | -625.06 | -1,250 | - | - | - | - |
Gain (Loss) on Sale of Assets | 367.7 | 487.77 | 10.92 | 14.24 | 40.58 | 0.98 |
Asset Writedown | -10,373 | -12,769 | - | - | - | - |
Pretax Income | -12,348 | -5,988 | 12,961 | 15,704 | 15,787 | 10,700 |
Income Tax Expense | -3,416 | -3,452 | 604.64 | 1,804 | 1,464 | 527.95 |
Earnings From Continuing Operations | -8,932 | -2,537 | 12,356 | 13,900 | 14,323 | 10,172 |
Minority Interest in Earnings | 737.87 | 739.05 | 130.23 | - | - | - |
Net Income | -8,194 | -1,797 | 12,486 | 13,900 | 14,323 | 10,172 |
Net Income to Common | -8,194 | -1,797 | 12,486 | 13,900 | 14,323 | 10,172 |
Net Income Growth | - | - | -10.17% | -2.95% | 40.80% | -23.17% |
Shares Outstanding (Basic) | 12 | 13 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 12 | 13 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | -7.59% | -2.63% | -2.61% | -1.59% | -0.37% | -1.73% |
EPS (Basic) | -655.57 | -134.77 | 911.50 | 988.20 | 1002.06 | 709.08 |
EPS (Diluted) | -655.82 | -135.00 | 911.50 | 988.00 | 1002.00 | 709.00 |
EPS Growth | - | - | -7.74% | -1.40% | 41.33% | -22.75% |
Free Cash Flow | 4,666 | 9,120 | 3,996 | 5,589 | 10,048 | 7,941 |
Free Cash Flow Per Share | 373.34 | 683.74 | 291.70 | 397.32 | 703.01 | 553.55 |
Dividend Per Share | 180.000 | 180.000 | - | - | - | - |
Gross Margin | 37.17% | 36.74% | 38.15% | 42.50% | 41.54% | 41.92% |
Operating Margin | -1.68% | 6.08% | 13.03% | 18.06% | 20.15% | 18.02% |
Profit Margin | -7.98% | -1.68% | 12.75% | 16.83% | 19.28% | 16.49% |
Free Cash Flow Margin | 4.54% | 8.53% | 4.08% | 6.77% | 13.53% | 12.87% |
EBITDA | 6,542 | 13,763 | 17,035 | 18,551 | 18,529 | 14,384 |
EBITDA Margin | 6.37% | 12.86% | 17.40% | 22.46% | 24.94% | 23.32% |
D&A For EBITDA | 8,264 | 7,254 | 4,278 | 3,633 | 3,561 | 3,264 |
EBIT | -1,722 | 6,509 | 12,757 | 14,918 | 14,968 | 11,119 |
EBIT Margin | -1.68% | 6.08% | 13.03% | 18.06% | 20.15% | 18.02% |
Effective Tax Rate | - | - | 4.67% | 11.49% | 9.28% | 4.93% |
Advertising Expenses | - | 1,180 | 1,299 | 588.44 | 449.68 | 137.29 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.